These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20943659)

  • 1. The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding.
    Park H; Adsit FG; Boyington JC
    J Biol Chem; 2010 Dec; 285(52):40762-70. PubMed ID: 20943659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
    Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for ligand recognition and activation of RAGE.
    Koch M; Chitayat S; Dattilo BM; Schiefner A; Diez J; Chazin WJ; Fritz G
    Structure; 2010 Oct; 18(10):1342-52. PubMed ID: 20947022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into the binding of the human receptor for advanced glycation end products (RAGE) by S100B, as revealed by an S100B-RAGE-derived peptide complex.
    Jensen JL; Indurthi VS; Neau DB; Vetter SW; Colbert CL
    Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1176-83. PubMed ID: 25945582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
    Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
    Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural insights into the oligomerization mode of the human receptor for advanced glycation end-products.
    Yatime L; Andersen GR
    FEBS J; 2013 Dec; 280(24):6556-68. PubMed ID: 24119142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional insights into RAGE activation by multimeric S100B.
    Ostendorp T; Leclerc E; Galichet A; Koch M; Demling N; Weigle B; Heizmann CW; Kroneck PM; Fritz G
    EMBO J; 2007 Aug; 26(16):3868-78. PubMed ID: 17660747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE).
    Xie J; Reverdatto S; Frolov A; Hoffmann R; Burz DS; Shekhtman A
    J Biol Chem; 2008 Oct; 283(40):27255-69. PubMed ID: 18667420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A fragment-based approach to discovery of Receptor for Advanced Glycation End products inhibitors.
    Kozlyuk N; Gilston BA; Salay LE; Gogliotti RD; Christov PP; Kim K; Ovee M; Waterson AG; Chazin WJ
    Proteins; 2021 Nov; 89(11):1399-1412. PubMed ID: 34156100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100B interaction with the receptor for advanced glycation end products (RAGE): a novel receptor-mediated mechanism for myocyte apoptosis postinfarction.
    Tsoporis JN; Izhar S; Leong-Poi H; Desjardins JF; Huttunen HJ; Parker TG
    Circ Res; 2010 Jan; 106(1):93-101. PubMed ID: 19910580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of S100A13 with C2 domain of receptor for advanced glycation end products (RAGE).
    Rani SG; Sepuru KM; Yu C
    Biochim Biophys Acta; 2014 Sep; 1844(9):1718-28. PubMed ID: 24982031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of S100 proteins to RAGE: an update.
    Leclerc E; Fritz G; Vetter SW; Heizmann CW
    Biochim Biophys Acta; 2009 Jun; 1793(6):993-1007. PubMed ID: 19121341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
    Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
    J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
    Sung HY; Dowarha D; Chou RH; Yu C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE).
    Degani G; Altomare AA; Colzani M; Martino C; Mazzolari A; Fritz G; Vistoli G; Popolo L; Aldini G
    Redox Biol; 2017 Apr; 11():275-285. PubMed ID: 28013188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of RAGE induces elevated O2- generation by mononuclear phagocytes in diabetes.
    Ding Y; Kantarci A; Hasturk H; Trackman PC; Malabanan A; Van Dyke TE
    J Leukoc Biol; 2007 Feb; 81(2):520-7. PubMed ID: 17095613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
    Penumutchu SR; Chou RH; Yu C
    PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
    Huang YK; Chou RH; Yu C
    J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release.
    Bianchi R; Kastrisianaki E; Giambanco I; Donato R
    J Biol Chem; 2011 Mar; 286(9):7214-26. PubMed ID: 21209080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization of Ca
    Kim I; Lee KO; Yun YJ; Jeong JY; Kim EH; Cheong H; Ryu KS; Kim NK; Suh JY
    Biochem Biophys Res Commun; 2017 Jan; 483(1):332-338. PubMed ID: 28017722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.